Search All UT System Experts

Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: Correlation of Smad4(Dpc4) immunostaining with pattern of disease progression

Christopher H. Crane, Gauri R. Varadhachary, John S. Yordy, Gregg A. Staerkel, Milind M. Javle, Howard Safran, Waqar Haque, Bridgett D. Hobbs, Sunil Krishnan, Jason B. Fleming, Prajnan Das, Jeffrey E. Lee, James L. Abbruzzese, Robert A. Wolff

Research output: Contribution to journal › Article › peer-review

253 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: Correlation of Smad4(Dpc4) immunostaining with pattern of disease progression'. Together they form a unique fingerprint.

Medicine & Life Sciences